DIVIDEND ANNOUNCEMENT: Amgen Inc (NASDAQ:AMGN) on 03/04/2020 declared a dividend of $1.6000 per share

Amgen Inc (NASDAQ:AMGN) on 03/04/2020 declared a dividend of $ 1.6000 per share payable on June 08, 2020 to shareholders of record as of May 18, 2020.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 3.1308093071% and has increased its dividends for 8 successive years.

Amgen Inc's market cap is $ 120,568,346,940 and has a PE ratio of 15.87. The stock price closed yesterday at $ 204.42 and has a 52 week low/high of $ 166.30 and $ 244.99.

Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co.'s products include: Enbrel® (etanercept), which is used in indications for the treatment of adult patients with moderately to severely active rheumatoid arthritis, patients with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and patients with active psoriatic arthritis; and Prolia® (denosumab), which is used for the treatment of postmenopausal women with osteoporosis at high risk of fracture or multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

For more information on Amgen Inc click here.